With the share price hovering just above $3 and CD12 results maybe coming before the end of the year I don’t think the folks at Nasdaq are in any hurry for us to join the club.
IMO that’s OK. I’d rather wait until CYDY actually has a product that is actually selling and bringing in revenue.

Then they’ll be welcoming us with open arms.